Evidence map›Paper›PMID 25683629›Full record

ArticlePediatric blood & cancer2015

Point-of-care end-tidal carbon monoxide reflects severity of hemolysis in sickle cell anemia.

Ashutosh Lal, Lasandra Patterson, Alisa Goldrich, Anne Marsh

2 registry-linked trialsAbstract readComparative Study
In one paragraph

Article in Pediatric blood & cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02530242 nacompletednot on this map

Point-of-Care End-Tidal Carbon Monoxide Measurement to Screen for Sickle Cell Disease

TypeinterventionalSponsorUCSF Benioff Children's Hospital OaklandRan2015 to 2015Enrolled32ConditionsSickle Cell AnemiaArmsEnd-tidal Carbon Monoxide Subjects, End-tidal Carbon Monoxide Controls
NCT07612345 phase1not yet recruitingnot on this mapstarted 2026, after this paper: background citation

Safety and Tolerability of Supratherapeutic Vitamin C Supplementation in Class A Glucose-6-Phosphate Dehydrogenase (G6PD A) Deficiency and Pyruvate Kinase Deficiency (PKD)

TypeinterventionalSponsorUniversity of UtahRan2026 to 2027Enrolled3ConditionsPyruvate Kinase Deficiency, Glucose 6 Phosphate Dehydrogenase DeficiencyArmsVitamin C
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 17 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Ashutosh LalHematology/Oncology, University of California San Francisco Benioff Children's Hospital, Oakland, California.
Lasandra Patterson
Alisa Goldrich
Anne Marsh
University of California, San Francisco · US

Funding

Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
NCATS NIH HHS UL1 TR000004
6 · The paper itself

Abstract

Carbon monoxide (CO) production from heme catabolism is increased with hemolysis. A portable end-tidal CO (ETCO) monitor was used to analyze breath samples in 16 children with sickle cell anemia (SCA, 5-14 years). Median (range) ETCO for SCA was 4.35 ppm (1.8-9.7) versus 0.80 ppm (0.2-2.3) for controls (P < 0.001). ETCOc >2.1 ppm provided sensitivity and specificity of 93.8% (69.8-99.8%) for detecting SCA. ETCO correlated with reticulocytosis (P = 0.015) and bilirubin (P = 0.009), and was 32% lower in children receiving hydroxyurea (P = 0.09). Point-of-care ETCO analysis may prove useful for non-invasive monitoring of hemolysis and as a screening test for SCA.

Indexed as

HemolysisTidal VolumeAdolescentAnemia, Sickle CellBilirubinCarbon MonoxideCase-Control StudiesChildChild, PreschoolExhalationFemaleFollow-Up StudiesHumansMaleMonitoring, PhysiologicPilot ProjectsBilirubinCarbon Monoxidehemoglobinopathiesred blood cell disorderssickle cell anemia

Identifiers

PMID25683629
PMCPMC4376621
OpenAlexW1930512711

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.